Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Shares of Denali Therapeutics Inc. DNLI were down 6.15% on April 6, after the company announced that partner Takeda TAK has decided to terminate their collaboration agreement to co-develop and
It has been a bumper year for Denali Therapeutics, Inc. DNLI. Shares of the company have surged 25.4% year to date compared with the industry’s gain of 2.7%. The stock has outperformed the sector
Information about Cookies on sharewise.com
This page uses Cookies. For proper functioning of the page Cookies are needed. You agree to using Cookies by clicking "OK".
More infos can be found in our Privacy declaration.
If you disagree this service is only available in very limited ways.
